Hypothyroidism is caused by which of the following anti-tubercular drugs?
Which of the following is least appropriate for the treatment of tetanus?
Common dose-dependent side effects of ethambutol include which of the following?
Which of the following drugs does not act on microtubules?
Which of the following drugs acts against Pseudomonas?
Carbapenem with the maximum seizure risk is:
Bacitracin acts on:
What is the drug of choice in Cryptococcal meningitis?
Ketoconazole is a medication used for which of the following purposes?
Among the following, which one is false about linezolid?
Explanation: ***Ethionamide*** - Ethionamide is a known **thiocarbamide derivative** that can inhibit thyroid hormone synthesis, leading to **hypothyroidism**. - It interferes with the binding of iodine to tyrosine residues within thyroglobulin, reducing the production of **T3 and T4 hormones**. *Streptomycin* - Streptomycin is an **aminoglycoside antibiotic** primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity**. - It does not have a well-documented association with thyroid dysfunction or hypothyroidism. *Thioacetazone* - Thioacetazone is a **second-line anti-tubercular drug** most commonly associated with severe skin reactions like **Stevens-Johnson syndrome (SJS)** and **toxic epidermal necrolysis (TEN)**. - While it can cause various side effects, hypothyroidism is not a typical or significant adverse effect. *Ethambutol* - Ethambutol's primary and most commonly recognized adverse effect is **ocular toxicity**, specifically **optic neuritis**, which can lead to red-green color blindness and decreased visual acuity. - It does not interfere with thyroid function or promote hypothyroidism.
Explanation: ***Doxycycline*** - While doxycycline is an antibiotic, it is **not considered a primary agent** for treating tetanus due to its generally inferior efficacy against *Clostridium tetani* compared to other options. - The main goal of antibiotic therapy in tetanus is to **eradicate vegetative forms of C. tetani** at the wound site, to stop further toxin production, which doxycycline is not optimally suited for. *Clindamycin* - **Clindamycin** is an effective antibiotic against *Clostridium tetani* and is often used in combination with metronidazole. - Its mechanism of action involves **inhibiting bacterial protein synthesis**, thereby preventing bacterial growth and toxin production. *Penicillin* - **Penicillin** was historically a first-line antibiotic for tetanus due to its bactericidal activity against *C. tetani*. - However, some concerns exist about its potential to **exacerbate seizures** due to its GABA antagonism, leading to a preference for metronidazole. *Metronidazole* - **Metronidazole** is the antibiotic of choice for tetanus as it is highly effective against anaerobic bacteria like *C. tetani*. - It is preferred over penicillin due to its similar efficacy and **lack of CNS excitability effects**.
Explanation: ***Optic neuritis*** - **Ethambutol** is known to cause dose-dependent **optic neuritis**, leading to decreased visual acuity and **red-green color blindness**. - This side effect is typically reversible if the drug is discontinued promptly, but delayed recognition can result in permanent visual impairment. *Red-orange urine* - **Red-orange discoloration of urine** is a characteristic side effect of **rifampin**, another antituberculosis drug, not ethambutol. - This side effect is benign and not indicative of organ dysfunction. *Nephrotoxicity* - **Nephrotoxicity** (kidney damage) is not a common or characteristic side effect of **ethambutol**. - Medications like **aminoglycosides** (e.g., gentamicin) and **NSAIDs** are more commonly associated with nephrotoxic effects. *Peripheral neuropathy* - **Peripheral neuropathy** is a common side effect associated with **isoniazid**, another antituberculosis medication. - It is often prevented or treated with concurrent administration of **pyridoxine (Vitamin B6)**.
Explanation: ***Fluconazole*** - **Fluconazole** is an **antifungal drug** [2] that acts by inhibiting **14-alpha-demethylase**, an enzyme crucial for **ergosterol synthesis** [1] in fungal cell membranes. - It does not interact with **microtubules** in any way; its mechanism is distinct from agents affecting cellular structural components. *Colchicine* - **Colchicine** is an anti-inflammatory drug primarily used for **gout**, which works by binding to **tubulin** and inhibiting its polymerization into **microtubules**. - This action disrupts **neutrophil migration**, phagocytosis, and degranulation, thereby reducing inflammation. *Vinblastine* - **Vinblastine** is a **vinca alkaloid** chemotherapy agent that inhibits **microtubule formation** by preventing the polymerization of tubulin. - This disruption leads to the arrest of cells in **metaphase** during mitosis, making it an effective anticancer drug. *Paclitaxel* - **Paclitaxel** is a **taxane** chemotherapy agent that stabilizes **microtubules** by preventing their depolymerization. - This stabilization arrests cells in the **G2/M phase** (particularly metaphase), inhibiting **cell division** and leading to apoptotic cell death.
Explanation: ***Piperacillin*** - **Piperacillin** is an extended-spectrum penicillin often combined with **tazobactam** to protect against beta-lactamase degradation. - It has significant activity against **Pseudomonas aeruginosa**, making it a key antibiotic for severe **Gram-negative infections**. *Methicillin* - **Methicillin** is a narrow-spectrum penicillinase-resistant penicillin primarily used for **MSSA (methicillin-sensitive Staphylococcus aureus)** infections. - It lacks activity against **Pseudomonas aeruginosa** and is associated with significant **nephrotoxicity**. *Cloxacillin* - **Cloxacillin** is a narrow-spectrum, **beta-lactamase-resistant penicillin** used for **Staphylococcal infections**, similar to methicillin. - It is **ineffective** against **Pseudomonas aeruginosa**, which has a different cell wall structure and resistance mechanisms. *Nafcillin* - **Nafcillin** is another **penicillinase-resistant penicillin** used mainly for serious **Staphylococcal infections** like endocarditis. - It does not offer coverage against **Pseudomonas aeruginosa** and is often administered intravenously for severe infections.
Explanation: ***Imipenem*** - **Imipenem** is primarily associated with a higher risk of seizures due to its ability to inhibit **GABAergic neurotransmission** in the central nervous system. - This effect is dose-dependent and more pronounced in patients with **renal impairment** or pre-existing CNS disorders, where drug accumulation occurs. *Meropenem* - While meropenem can also cause seizures, its **GABA antagonistic effect** is less potent than imipenem, resulting in a lower incidence of this adverse event. - It is generally considered safer than imipenem for patients at risk of seizures. *Ertapenem* - Ertapenem has an even lower propensity for causing seizures compared to imipenem and meropenem. - It is often preferred in outpatient settings due to its **once-daily dosing** and favorable safety profile regarding CNS adverse effects. *Doripenem* - Doripenem also has a **low seizure potential**, similar to meropenem and ertapenem. - Its **pharmacokinetic profile** and CNS penetration differ, but it is not associated with the same high risk as imipenem.
Explanation: ***Cell wall*** - **Bacitracin** inhibits bacterial **cell wall synthesis** by interfering with the dephosphorylation of the C55-isoprenyl pyrophosphate lipid carrier molecule. - This lipid carrier is essential for transporting **peptidoglycan** precursors across the bacterial membrane to the growing cell wall. *Cell membrane* - While bacitracin does target the synthesis pathway for the cell wall which is adjacent to the membrane, its direct action is not on the integrity or function of the **cell membrane** itself. - Drugs that act directly on the cell membrane typically disrupt its permeability, leading to leakage of cytoplasmic contents. *Nucleic acid* - **Nucleic acid** synthesis inhibitors (e.g., fluoroquinolones, rifampin) target DNA replication, transcription, or repair mechanisms. - Bacitracin does not interfere with the synthesis or function of bacterial **DNA** or **RNA**. *Ribosome* - **Ribosome** inhibitors (e.g., macrolides, tetracyclines) target bacterial protein synthesis, binding to either the 30S or 50S ribosomal subunit. - Bacitracin's mechanism of action is distinct from protein synthesis inhibition.
Explanation: ***Amphotericin B*** - **Amphotericin B** (in combination with flucytosine) is the **drug of choice** for **induction therapy** in **cryptococcal meningitis** due to its potent fungicidal activity against *Cryptococcus neoformans*. - Its broad-spectrum activity and ability to penetrate the **central nervous system** make it highly effective against severe fungal infections. - Following induction, **fluconazole** is used for consolidation and maintenance therapy. *Pentostatin* - **Pentostatin** is an antineoplastic agent used primarily in the treatment of **hairy cell leukemia**, not fungal infections. - It works by inhibiting **adenosine deaminase**, preventing DNA synthesis in lymphocytes. *Clotrimazole* - **Clotrimazole** is a topical azole antifungal agent used for **superficial fungal infections** like candidiasis or ringworm. - It is not effective for systemic or severe infections like **cryptococcal meningitis** and does not penetrate the CNS adequately. *Zidovudine* - **Zidovudine** (AZT) is an **antiretroviral drug** used in the treatment of **HIV/AIDS**. - It specifically targets the **reverse transcriptase** enzyme of HIV and has no antifungal properties.
Explanation: ***Antifungal agent*** - **Ketoconazole** is a broad-spectrum imidazole antifungal agent used to treat various **superficial and systemic fungal infections**. - It works by inhibiting the synthesis of **ergosterol**, a crucial component of fungal cell membranes, leading to increased membrane permeability and fungal cell death. *Antibacterial* - **Antibacterial agents** target bacteria, and while some antifungals may have minor antibacterial properties, ketoconazole's primary mechanism and clinical use are not focused on bacteria. - Its mechanism of action, targeting fungal ergosterol synthesis, is distinct from the mechanisms of typical antibacterial drugs. *Antiviral agent* - **Antiviral agents** are specifically designed to inhibit viral replication and are not effective against fungal infections. - Ketoconazole has no significant antiviral activity. *Chemotherapeutic agent* - **Chemotherapeutic agents** are primarily used in the treatment of cancer by targeting rapidly dividing cells. - While some medications can have multiple uses, ketoconazole is not classified or used as a primary chemotherapeutic agent; its main role is in treating fungal infections.
Explanation: ***It is the drug of choice for enterococcal endocarditis*** - While linezolid is active against enterococci, it is **not the drug of choice for enterococcal endocarditis**. The standard treatment for **enterococcal endocarditis** is a combination of a penicillin (like ampicillin) or vancomycin with an **aminoglycoside** (like gentamicin) due to synergistic bactericidal activity. - Linezolid is primarily bacteriostatic against enterococci and is reserved for situations where first-line agents are not effective or cannot be used, such as in cases of **vancomycin-resistant enterococci (VRE)**. *It is active against vancomycin-resistant enterococci* - Linezolid is an important antibiotic specifically used for treating infections caused by **vancomycin-resistant enterococci (VRE)**, including *Enterococcus faecium* and *Enterococcus faecalis*. - Its mechanism of action, inhibiting protein synthesis early, allows it to bypass the resistance mechanisms that affect vancomycin. *It can be administered orally as well as by i.v. infusion* - Linezolid has **excellent oral bioavailability**, meaning it is well absorbed from the gastrointestinal tract, making it a valuable option for both oral and intravenous administration. - This characteristic allows for seamless transition from intravenous to oral therapy, facilitating outpatient treatment for certain infections. *It inhibits bacterial protein synthesis at an early step* - Linezolid belongs to the oxazolidinone class of antibiotics and works by specifically binding to the **23S ribosomal RNA** of the 50S subunit. - This binding prevents the formation of the **N-formylmethionyl-tRNA complex**, which is crucial for the initiation of bacterial protein synthesis.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free